Nov 15 (Reuters) - Collplant Biotechnologies Ltd
CPTG.F :
* COLLPLANT, TEL AVIV UNIVERSITY AND SHEBA MEDICAL CENTER
JOIN
FORCES TO CO-DEVELOP RHCOLLAGEN-BASED 3D BIOPRINTED HUMAN
INTESTINE MODEL FOR DRUG DISCOVERY AND PERSONALIZED TREATMENT OF
ULCERATIVE COLITIS
* COLLPLANT BIOTECHNOLOGIES - CO TO FUND DEVELOPMENT AND
RECEIVE
EXCLUSIVE LICENSE TO MANUFACTURE AND COMMERCIALIZE HUMAN
INTESTINE TISSUE MODEL
Source text for Eikon: ID:nPn40Kpg2a
Further company coverage: CPTG.F
((Reuters.Briefs@thomsonreuters.com;))